We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$279B
AUM Growth
-$8.2B
Cap. Flow
+$8.77B
Cap. Flow %
3.14%
Top 10 Hldgs %
16.93%
Holding
3,614
New
79
Increased
2,461
Reduced
704
Closed
105

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$441M
2
AVGO icon
Broadcom
AVGO
+$328M
3
PFE icon
Pfizer
PFE
+$292M
4
TSLA icon
Tesla
TSLA
+$252M
5
IBM icon
IBM
IBM
+$209M

Sector Composition

Rank Sector Weight
1 Technology 19.91%
2 Financials 13.22%
3 Healthcare 13.19%
4 Consumer Discretionary 10.07%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CODX
3401
Co-Diagnostics
CODX
$5.31M
$36K ﹤0.01%
369
OVID icon
3402
Ovid Therapeutics
OVID
$414M
$36K ﹤0.01%
19,452
PXLW icon
3403
Pixelworks
PXLW
$38.2M
$36K ﹤0.01%
1,830
QTTB icon
3404
Q32 Bio
QTTB
$466M
$36K ﹤0.01%
+1,221
New +$49.8K
DBTX
3405
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$36K ﹤0.01%
+10,345
New +$47.1K
INFI
3406
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$36K ﹤0.01%
29,948
SPPI
3407
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$36K ﹤0.01%
+82,687
New +$81.2K
AQB icon
3408
AquaBounty Technologies
AQB
$4.66M
$35K ﹤0.01%
+2,202
New +$58K
PYXS icon
3409
Pyxis Oncology
PYXS
$168M
$35K ﹤0.01%
+17,739
New +$46.3K
STRM
3410
DELISTED
Streamline Health Solutions
STRM
$35K ﹤0.01%
+1,935
New +$43.4K
FTK icon
3411
Flotek Industries
FTK
$852M
$34K ﹤0.01%
5,581
MIMO
3412
DELISTED
Airspan Networks Holdings Inc
MIMO
$34K ﹤0.01%
16,700
SLS icon
3413
SELLAS Life Sciences
SLS
$1.97B
$33K ﹤0.01%
+16,238
New +$44.8K
NOVN
3414
DELISTED
Novan, Inc. Common Stock
NOVN
$33K ﹤0.01%
17,180
SUP
3415
DELISTED
Superior Industries International
SUP
$32K ﹤0.01%
10,350
TSHA icon
3416
Taysha Gene Therapies
TSHA
$1.68B
$32K ﹤0.01%
16,140
-74,571
-82% -$271K
ALPP
3417
DELISTED
Alpine 4 Holdings Inc
ALPP
$32K ﹤0.01%
7,198
AXLA
3418
DELISTED
Axcella Health Inc. Common Stock
AXLA
$32K ﹤0.01%
730
FNCH
3419
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$32K ﹤0.01%
626
-460
-42% -$32K
APLD icon
3420
Applied Digital
APLD
$7.89B
$31K ﹤0.01%
17,721
CDZI icon
3421
Cadiz
CDZI
$251M
$31K ﹤0.01%
15,822
DARE icon
3422
Dare Bioscience
DARE
$18.3M
$31K ﹤0.01%
2,544
IBIO icon
3423
iBio
IBIO
$69.5M
$31K ﹤0.01%
+362
New +$49.8K
NCMI icon
3424
National CineMedia
NCMI
$376M
$31K ﹤0.01%
+4,633
New +$55.9K
RCAT icon
3425
Red Cat Holdings
RCAT
$1.15B
$31K ﹤0.01%
18,398

Similar funds

Charles Schwab's Q3 2022 Portfolio in Review

As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.

  • Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
  • Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
  • Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
  • Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
  • Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
  • Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
  • Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.